JAK/STAT Signaling


Various ligands including cytokines (e.g. interferons and interleukins), hormones (e.g. erythropoietin and growth hormone) and their cell surface receptors activate JAK proteins, which autophosphorylate, and then phosphorylate the receptor. Subsequently, JAKs phosphorylate a specific tyrosine residue on the STAT protein, promoting dimerization via SH2 domains. The activated STATs form homo-/heterodimers and translocate to the nucleus to trigger target gene transcription. In addition, suppressors of cytokine signaling (SOCS) family inhibit receptor signaling via homologous or heterologous feedback regulation. Dysregulation in JAK/STAT signaling is associated with diseases such as atherosclerosis, immunodeficiencies and cancer.
-
BA7641 MyricanoneSummary: A compound isolated from the bark of the tree. -
BA8685 PhellopterinSummary: Phellopterin is a natural product. -
BA5012 TropisetronSummary: Tropisetron (SDZ-ICS-930freebase) is a 5-HT3 receptor antagonist. -
BA6006 CirsilineolSummary: Cirsilineol is a natural flavonoid compound that selectively inhibits IFN-γ/STAT1/T-bet signaling in intestinal T cells. -
BA6391 DHFR-IN-4Summary: DHFR-IN-4 is a potent dihydrofolate reductase inhibitor. -
BA6423 3-DemethylnobiletinSummary: 3'-Demethylnobiletin is a derivative of Nobiletin, 3'-Demethylnobiletin is a polymethoxyflavonoid present in citrus fruits. -
BA6455 HirsutenoneSummary: Hirsutenone, an active diheptanone contained in alder, has a variety of biological activities including anti-inflammatory, anti-tumor and anti-atopic dermatitis. -
A8197 Compound 561 CitationTarget: EGFRSummary: REGFR inhibitor -
A8199 PD153035 hydrochloride1 CitationTarget: EGFRSummary: Potent EGFR inhibitor -
A3012 Ruxolitinib (INCB018424)12 CitationTarget: JAKSummary: JAK1 and JAK2 inhibitor

